Vitamin D dosing for infectious and immune disorders

Thorax

Volumn 70, Issue 10, 2015, Pages 919-920

  Weiss, Scott T ^a   Litonjua, Augusto A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; VITAMIN D;

DISEASE DURATION; DRUG EFFECT; EDITORIAL; FEEDBACK SYSTEM; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFECTION RISK; PATIENT MONITORING; PRIORITY JOURNAL; RADIATION EXPOSURE; ULTRAVIOLET B RADIATION; UPPER RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; FEMALE; MALE; RESPIRATORY TRACT DISEASES; VIRUS DISEASES;

FEMALE; HUMANS; MALE; RESPIRATORY TRACT DISEASES; VIRUS DISEASES; VITAMIN D;

EID: 84942325028     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207334     Document Type: Editorial

References (15)

1. Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006;92:17-25.
2. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010;121:297-300.
3. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol 2014;144(Pt A):138-45.
4. Sabetta JR, DePetrillo P, Cipriani RJ, et al. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 2010;5:e11088.
5. Hollis BW, Wagner CL. Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 2013;98:4619-28.
6. Hollis BW, Wagner CL, Drezner MK, et al. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol 2007;103:631-4.
7. Luxwolda MF, Kuipers RS, Kema IP, et al. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 2012;108:1557-61.
8. Luxwolda MF, Kuipers RS, Kema IP, et al. Vitamin D status indicators in indigenous populations in East Africa. Eur J Nutr 2013;52:1115-25.
9. Martineau AR, Hanifa Y, Witt KD, et al. Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu). Thorax 2015;70:953-60.
10. Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009;29:3675-84.
11. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIA randomized controlled trial. JAMA 2012;308:1333-9.
12. Martineau AR, James WY, Hooper RLM et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. The Lancet Respiratory Medicine 2015;3:120-30.
13. Martineau AR, MacLaughlin BD, Hooper RL, et al. Double blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 2015;70:451-7.
14. Camargo CA, Ganmaa D, Frazier AL, et al. Randomized Trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012;130e561-7.
15. Laaksi I, Ruohola JP, Mattila V, et al. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomised, double blinded trial among young Finnish men. J Infect Dis 2010;202:809-14.